跳到主内容
精选行业洞察美国 FDAT1067

Determination That VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, Injection, 50 units/50 milliliters (1 unit/milliliters) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

·12 天前·来源:美国 FDA

🤖 AI 摘要

The Food and Drug Administration (FDA or Agency) has determined that VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, injection, 50 units/50 milliliters (mL) (1 unit/mL) was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, injection, 50 units/ 50 mL (1 unit/mL), if all other legal and regulatory requirements are met.

分析模型:rule-based-v3 · 07-09 06:59

评分详情

综合分 67/100

信源权威

95

影响范围

70

时效性

80

合规紧急

40

行业关注

35

Federal Register: FDA Notices (官方通知)
操作:

相关推荐